PMEF
LAB icon

Point72 Middle East FZE’s Standard BioTools LAB Stock Holding History

Point72 Middle East FZE’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-9,314
Closed -$18.2K – 1831
2023
Q1 		$18.2K Buy
+9,314
New +$18.4K ﹤0.01% 1435

Other funds holding LAB

CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
ICM
Indaba Capital Management San Francisco, California $33.8M AUM 33.83% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Point72 Middle East FZE's LAB Position: Q2 2023 in Review

Point72 Middle East FZE sold out of Standard BioTools (LAB) in Q2 2023, closing a stake of 9,314 shares — an estimated $18.2K sold.

Point72 Middle East FZE first reported a position in LAB in Q1 2023 and held it in 1 quarter. The position peaked at $18.2K in Q1 2023. 66 funds tracked by Wall St. Rank hold LAB as of Q2 2023.

  • Point72 Middle East FZE reported no remaining Standard BioTools position as of Q2 2023 after selling out during the quarter.
  • Point72 Middle East FZE sold 9,314 Standard BioTools shares in Q2 2023, an estimated $18.2K.
  • Point72 Middle East FZE first reported a position in Standard BioTools in Q1 2023 and held it in 1 quarter.
  • Point72 Middle East FZE's Standard BioTools position peaked at $18.2K in Q1 2023.
  • 66 funds tracked by Wall St. Rank held Standard BioTools as of Q2 2023.

Based on Point72 Middle East FZE's 13F filing for Q2 2023, filed 14 Aug 2023.